+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Saquinavir"

HIV Drugs and Injectables Market Report 2024-2034 - Product Thumbnail Image

HIV Drugs and Injectables Market Report 2024-2034

  • Report
  • July 2024
  • 288 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

Saquinavir is an antiviral drug used to treat HIV infection and AIDS. It is a protease inhibitor, meaning it works by blocking the action of the HIV protease enzyme, which is essential for the virus to replicate. Saquinavir is usually used in combination with other antiretroviral drugs to treat HIV infection. It is also used to prevent HIV infection in people who are at high risk of contracting the virus. Saquinavir is available in both capsule and oral solution form. It is usually taken twice daily with food. Common side effects of saquinavir include nausea, vomiting, diarrhea, and headache. More serious side effects include liver damage, kidney failure, and an increased risk of heart attack and stroke. The saquinavir market is highly competitive, with several major pharmaceutical companies offering the drug. Companies such as Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer are all involved in the market. Show Less Read more